Close Menu

Researchers from the German Cancer Research Center are looking into which genes are responsible for the survival of cancer cells, according to a press release posted at ScienceBlog. The team found that the cells rely on the tension among specific protein fibers to multiply, and are hoping to develop anticancer drugs that specifically target these proteins. The idea is that once the proteins are switched off, the cancer cells will die, according to the release.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.